Bintrafusp Alfa, a Bifunctional Fusion Protein Targeting TGF-β and PD-L1, in Second-Line Treatment of Patients With NSCLC: Results From an Expansion Cohort of a Phase 1 Trial is a research paper published in Journal of Thoracic Oncology (2020). On theSindex it has a DataRank of 0. It has been cited 222 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Instituto de Salud Carlos III
Grant: CD16/12/00442
Instituto de Salud Carlos III
Grant: DTS17/00089
Instituto de Salud Carlos III
Grant: PI14/01964
Instituto de Salud Carlos III
Grant: PI17/00778
Instituto de Salud Carlos III
Grant: PIE15/00076
Intramural NIH HHS
Grant: ZIA BC010666
Celgene
GlaxoSmithKline
Bristol-Myers Squibb
Eli Lilly and Company
AstraZeneca
Boehringer Ingelheim
Merck KGaA
Pfizer
Sanofi España
Bayer
PharmaMar
Servier
European Commission
Merck Sharp and Dohme
Mundipharma AB
Janssen Biotech
Novartis Farmacéutica
Roche
AbbVie
Takeda Pharmaceutical Company
FWCI
10.98
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals